Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA5 | P11021 | 2/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CNR1 | P21554 | 13/20 | 0.46 |
| ▸ | CNR2 | P34972 | 12/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | GPR18 | Q14330 | 3/20 | 0.41 |
| ▸ | GPR55 | Q9Y2T6 | 3/20 | 0.41 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.41 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11233052 | 0.89 | CNR2 (0.51) | SMN1; SMN2CNR1CNR2NR5A2NR5A1 | |
| SCHEMBL11302567 | 0.87 | CNR2 (0.54) | CNR1CNR2NR5A2NR5A1 | |
| SCHEMBL10948426 | 0.84 | CNR2 (0.51) | CNR1CNR2GPR18GPR55 | |
| SCHEMBL11796196 | 0.83 | CNR2 (0.54) | CNR1CNR2GPR18GPR55 | |
| SCHEMBL3812708 | 0.82 | HSPA5 (0.59) | HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL29975834 | 0.82 | HSPA5 (0.59) | HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL2705479 | 0.82 | CNR1 (0.38) | HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL10947686 | 0.82 | CNR2 (0.46) | CNR1CNR2GPR18GPR55 | |
| SCHEMBL3090860 | 0.80 | CNR2 (0.37) | HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL767214 | 0.80 | CNR2 (0.53) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240166672-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-05-23 | — | — | US | disclosed |
| EP-4317166-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME, AND USE APPLICATION FOR SAME | Sumitomo Chemical Company Limited (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-20090316084-A1 | Method of Producing Polarizing Plate, Polarizing Plate, and Liquid Crystal Display | KONICA MINOLTA OPTO, INC. (JP) | 2009-12-24 | — | — | US | disclosed |
| US-20090286098-A1 | Optical Film, Method of Producing the Same and Image Displaying Apparatus Employing the Optical Film | KONICA MINOLTA OPTO, INC. (JP) | 2009-11-19 | — | — | US | disclosed |
| US-20090135345-A1 | Polarizing Plate Protective Film, Film Producing Method, Polarizing Plate, and Liquid Crystal Display | KONICA MINOLTA OPTO, INC. (JP) | 2009-05-28 | — | — | US | disclosed |
| US-20090074989-A1 | Cellulose Ester Film, Manufacturing Method Thereof, Optical Film, Polarizing Plate and Liquid Crystal Display | KONICA MINOLTA OPTO, INC. (JP) | 2009-03-19 | — | — | US | disclosed |
| US-20060233973-A1 | Cellulose ester film, manufacturing method thereof, optical film, polarizing plate and liquid crystal display | KONICA MINOLTA OPTO, INC. | 2006-10-19 | — | — | US | disclosed |
| US-20050247913-A1 | Phosphorous ester compound, process for producing the same, and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-11-10 | — | — | US | disclosed |
| EP-0823435-B1 | Phosphites, process for producing the same and their use | SUMITOMO CHEMICAL CO (JP) | 2001-11-21 | — | — | EP | disclosed |
| US-6242514-B1 | CYCLIC PHOSPHATE OR PHOSPHONATE; HEAT AND OXIDATION STABILIZER ESPECIALLY FOR OLEFIN POLYMERS AND ENGINEERING THERMOPLASTICS | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2001-06-05 | — | — | US | disclosed |
| US-6075159-A | USE AS A STABILIZER FOR AN ORGANIC MATERIAL SUCH AS THERMOPLASTIC RESINS, THERMOSETTING RESINS, NATURAL OR SYNTHETIC RUBBERS, MINERAL OILS, LUBRICATING OILS, ADHESIVES AND PAINTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-06-13 | — | — | US | disclosed |
| US-5902516-A | STABILIZER FOR THERMOPLASTIC POLYOLEFIN OR ENGINEERING RESINS | SUMITOMO CHEMICAL CO., LTD (JP) | 1999-05-11 | — | — | US | disclosed |
| US-5891939-A | POLYMER STABILIZERS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-04-06 | — | — | US | disclosed |
| US-5874494-A | DETERIORATION STABILIZER FOR THERMOPLASTIC RESIN; OXIDATION RESISTANCE, DISCOLORATION INHIBITION, HEAT RESISTANCE, CROSSLINKING INHIBITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-02-23 | — | — | US | disclosed |
| US-5847187-A | Organic phosphorous compound, a process for producing the same and a use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-12-08 | — | — | US | disclosed |
| US-5830936-A | THERMAL STABILIZERS FOR POLYOLEFINS AND ENGINEERING PLASTICS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-11-03 | — | — | US | disclosed |
| EP-0823435-A2 | Phosphites, process for producing the same and their use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-02-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166672-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME | EBPL, ACSL6, ACSL3 | HSPA5 4448/4885CYP2C9 1363/4885CYP2C19 1902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.